MARKET

COLL

COLL

Collegium Pharmaceutical Inc
NASDAQ
37.80
-1.53
-3.89%
After Hours: 37.71 -0.09 -0.24% 16:26 05/08 EDT
OPEN
39.65
PREV CLOSE
39.33
HIGH
40.50
LOW
37.61
VOLUME
697.98K
TURNOVER
--
52 WEEK HIGH
50.79
52 WEEK LOW
26.72
MARKET CAP
1.22B
P/E (TTM)
18.56
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Regeneron (REGN) and Collegium Pharmaceutical (COLL)
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT), Celldex (CLDX) and Collegium Pharmaceutical (COLL)
TipRanks · 2d ago
COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results
Barchart · 2d ago
Collegium Pharmaceutical Leans Into Growth After Earnings
TipRanks · 2d ago
Collegium Pharmaceutical (COLL) Earnings Growth Far Outpaces Revenue And Tests Cautious Narratives
Simply Wall St · 2d ago
Collegium (COLL) Q1 2026 Earnings Transcript
The Motley Fool · 2d ago
Collegium outlines $805M-$825M 2026 product revenue outlook while planning to close $650M AZSTARYS deal in Q2
Seeking Alpha · 2d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)
TipRanks · 2d ago
More
About COLL
Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company. The Company has developed, licensed, and acquired a portfolio of products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. Its commercial products include Jornay PM (Jornay), Belbuca, Xtampza ER (Xtampza), Nucynta ER and Nucynta IR (Nucynta Products), and Symproic in the United States. Its Jornay is a central nervous system (CNS) stimulant prescription medicine for the treatment of ADHD. The Belbuca is a buccal film that contains buprenorphine for severe and persistent pain. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. The Xtampza ER is a pain treatment option designed with abuse deterrent properties. The Nucynta Products are ER and IR oral formulations of tapentadol. Nucynta ER is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic.

Webull offers Collegium Pharmaceutical Inc stock information, including NASDAQ: COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.